Pharmaceutical Investing Zynerba Pharmaceuticals Reports First Quarter 2018 Financial Results and Operational Highlights
Pharmaceutical Investing Zynerba Pharmaceuticals Initiates Open-Label Phase 2 Trial of ZYN002 in Developmental and Epileptic Encephalopathies
RUA GOLD Begins Drilling at Cumberland Target in the Reefton Goldfield, Following up on a 20.7m Intercept of 62g/t Gold